These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10719724)

  • 1. Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease.
    Hardingham JE; Hewett PJ; Sage RE; Finch JL; Nuttall JD; Kotasek D; Dobrovic A
    Int J Cancer; 2000 Jan; 89(1):8-13. PubMed ID: 10719724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of cytokeratin 20 mRNA in the peripheral blood of patients with colorectal cancer by immunomagnetic bead enrichment and real-time reverse transcriptase-polymeras chain reaction.
    Guo J; Xiao B; Jin Z; Qin L; Chen J; Chen H; Zhang X; Liu Z
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1279-84. PubMed ID: 16048578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients.
    Shen C; Hu L; Xia L; Li Y
    Jpn J Clin Oncol; 2008 Nov; 38(11):770-6. PubMed ID: 18845519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells.
    Lloyd JM; McIver CM; Stephenson SA; Hewett PJ; Rieger N; Hardingham JE
    Clin Cancer Res; 2006 Jan; 12(2):417-23. PubMed ID: 16428481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical detection of circulating esophageal carcinoma cells by immunomagnetic separation.
    Nakamura T; Yasumura T; Hayashi K; Eguchi R; Ide H; Takasaki K; Kasajima T
    Anticancer Res; 2000; 20(6C):4739-44. PubMed ID: 11205210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction.
    de Cremoux P; Extra JM; Denis MG; Pierga JY; Bourstyn E; Nos C; Clough KB; Boudou E; Martin EC; Müller A; Pouillart P; Magdelénat H
    Clin Cancer Res; 2000 Aug; 6(8):3117-22. PubMed ID: 10955792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of cytokeratin-20-positive cells in preoperative and postoperative blood samples from colorectal cancer patients by real-time RT-PCR.
    Šamija I; Lukač J; Mubrin MK; Kirac I; Kovačević D; Kusić Z
    Int J Biol Markers; 2013 Jun; 28(2):174-81. PubMed ID: 23558939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients.
    Wong SC; Chan CM; Ma BB; Hui EP; Ng SS; Lai PB; Cheung MT; Lo ES; Chan AK; Lam MY; Au TC; Chan AT
    Clin Cancer Res; 2009 Feb; 15(3):1005-12. PubMed ID: 19188172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical evaluation of real-time reverse transcriptase-polymerase chain reaction for the quantitative detection of cytokeratin 20 mRNA in colorectal cancer patients.
    Dandachi N; Balic M; Stanzer S; Halm M; Resel M; Hinterleitner TA; Samonigg H; Bauernhofer T
    J Mol Diagn; 2005 Nov; 7(5):631-7. PubMed ID: 16258162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow.
    Weitz J; Kienle P; Magener A; Koch M; Schrödel A; Willeke F; Autschbach F; Lacroix J; Lehnert T; Herfarth C; von Knebel Doeberitz M
    Clin Cancer Res; 1999 Jul; 5(7):1830-6. PubMed ID: 10430088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of circulating tumor cells in colorectal cancer by immunobead-PCR is a sensitive prognostic marker for relapse of disease.
    Hardingham JE; Kotasek D; Sage RE; Eaton MC; Pascoe VH; Dobrovic A
    Mol Med; 1995 Nov; 1(7):789-94. PubMed ID: 8612201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokeratin 20 is not a tissue-specific marker for the detection of malignant epithelial cells in the blood of colorectal cancer patients.
    Bustin SA; Gyselman VG; Siddiqi S; Dorudi S
    Int J Surg Investig; 2000; 2(1):49-57. PubMed ID: 12774338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients.
    Denis MG; Lipart C; Leborgne J; LeHur PA; Galmiche JP; Denis M; Ruud E; Truchaud A; Lustenberger P
    Int J Cancer; 1997 Oct; 74(5):540-4. PubMed ID: 9355978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer.
    Cohen SJ; Alpaugh RK; Gross S; O'Hara SM; Smirnov DA; Terstappen LW; Allard WJ; Bilbee M; Cheng JD; Hoffman JP; Lewis NL; Pellegrino A; Rogatko A; Sigurdson E; Wang H; Watson JC; Weiner LM; Meropol NJ
    Clin Colorectal Cancer; 2006 Jul; 6(2):125-32. PubMed ID: 16945168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P53 mutations in primary and metastatic tumors and circulating tumor cells from colorectal carcinoma patients.
    Khan ZA; Jonas SK; Le-Marer N; Patel H; Wharton RQ; Tarragona A; Ivison A; Allen-Mersh TG
    Clin Cancer Res; 2000 Sep; 6(9):3499-504. PubMed ID: 10999735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissemination of tumor cells in patients undergoing surgery for colorectal cancer.
    Weitz J; Kienle P; Lacroix J; Willeke F; Benner A; Lehnert T; Herfarth C; von Knebel Doeberitz M
    Clin Cancer Res; 1998 Feb; 4(2):343-8. PubMed ID: 9516921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of hematogenous tumor cell dissemination in patients with stage II colorectal cancer.
    Koch M; Kienle P; Kastrati D; Antolovic D; Schmidt J; Herfarth C; von Knebel Doeberitz M; Weitz J
    Int J Cancer; 2006 Jun; 118(12):3072-7. PubMed ID: 16425256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer.
    Iinuma H; Okinaga K; Egami H; Mimori K; Hayashi N; Nishida K; Adachi M; Mori M; Sasako M
    Int J Oncol; 2006 Feb; 28(2):297-306. PubMed ID: 16391782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.